<DOC>
	<DOCNO>NCT02312024</DOCNO>
	<brief_summary>Registry use CytoSorb® adsorber ICU patient .</brief_summary>
	<brief_title>International Registry Use CytoSorb Adsorber</brief_title>
	<detailed_description>The aim registry record use CytoSorb® real life condition many case possible ( preferably , least , representative sample ) . All CytoSorb® application different clinical setting patient treat technology Germany , Austria Switzerland ( target population ) plan include . The objective registry collection real-life data broad scale , centralize , structure comprehensive documentation , control data exchange . The gathered information use augment knowledge clinical efficacy technology , optimize quality therapeutic application , identify promptly handle possible complication relate use CytoSorb® . The registry record relevant information course product use , e.g . diagnosis , comorbidities , course condition , treatment , concomitant medication clinical laboratory parameter . The registry inform physicians different medical specialty range possible application CytoSorb® invite contribute experience registry . This do give access data result periodic analysis ( contribute participant ) , via publication result ( participant external interested party ) The CytoSorb® registry provide data base justify optimized decision . An active form data collection data prospectively collect qualified staff particularly suit purpose . Registry data might help close knowledge gap open practical issue . Due patient group 's heterogeneity , registry identify sub-groups , assess risk-benefit-profile examine safety profile . Registry data absolutely essential assess therapy 's significance within healthcare landscape . Institutions contribute data registry benefit several way : They obtain continuous retrospective feedback result , data periodically compare data participate site , get access regularly publish analysis result participant . On basis data , establish quality monitor optimize use CytoSorb® . The planned endpoint allow comprehensive description CytoSorb® efficacy term several indication-relevant aspect . Together monitor application safety , data build basis establish benchmark promote high treatment quality .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<criteria>Use CytoSorb® adsorber Age ≥ 18 year Signed informed consent none</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>CytoSorb adsorber</keyword>
	<keyword>sepsis</keyword>
	<keyword>cytokine</keyword>
	<keyword>hemofiltration</keyword>
	<keyword>hemadsorption</keyword>
	<keyword>inflammation</keyword>
</DOC>